RVZ News

A recent study from the University of Würzburg unveiled a key enzyme involved in producing selenoproteins, opening new strategies for treating certain types of cancer in children.

Professors Ivo Boneca, Mark Brönstrup, and Christophe Zimmer have been awarded one of the most prestigious European research prizes, an ERC Synergy Grant worth eleven million euros.

The competition for the multi-million euro federal and state funding programme is entering its final phase. JMU has submitted two proposals and the results of the evaluation will be available in May 2025.

Some cancer drugs cause severe side effects because they are not working accurately enough. A team at the University of Würzburg led by biochemist Caroline Kisker has now discovered why.

Researchers at the University of Würzburg, led by Caroline Kisker in cooperation with Claudia Höbartner, discovered how the protein XPD detects a severe DNA damage and controls its repair.

Professor Bernhard Nieswandt is investigating a cellular mechanism in blood platelets that appears to play a crucial role in inflammatory diseases. He has been awarded an ERC Advanced Grant for his work.

One step further: One JMU research project on nucleic acid research and technologies has qualified for the next round in the competition for the prestigious research grant.

A precursor of cholesterol, previously categorised as harmful, can protect cancer cells from cell death. This finding, published in Nature, opens new doors for cancer research.

Good news for researchers working with high-resolution fluorescence microscopy: Biocompatible molecular rulers are available for the first time to calibrate the latest super-resolution microscopy methods.

José Pedro Friedmann Angeli has been awarded a European research prize worth two million euros. With his work, the Würzburg professor wants to contribute to innovative therapies against cancer.

Their work is most frequently cited in publications of other scientists. Researchers from the University of Würzburg are therefore included in the Highly Cited Researchers 2023 list.

Why is the SARS-CoV-2 coronavirus able to spread so efficiently? Various hypotheses are still circulating in the scientific community. A group of researchers from Würzburg has now found groundbreaking answers.

This specific Index looks at the current state of biomedical science around the world and what its renaissance might mean for patients. In this context, the Rudolf Virchow Center was selected to write an article about ongoing research at our center.